Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-52089
Mol Cell Endocrinol 2022 Dec 01;558:111775. doi: 10.1016/j.mce.2022.111775.
Show Gene links Show Anatomy links

Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells.

Costa AJ , Lemes RMR , Bartolomeo CS , Nunes TA , Pereira GC , Oliveira RB , Gomes AL , Smaili SS , Maciel RMB , Newson L , Ramirez AL , Okuda LH , Prado CM , Stilhano RS , Ureshino RP .


Abstract
Gender-bias in COVID-19 severity has been suggested by clinical data. Experimental data in cell and animal models have demonstrated the role of sex hormones, particularly estrogens, in viral infections such as in COVID-19. SARS-CoV-2 uses ACE2 as a receptor to recognize host cells, and the protease TMPRSS2 for priming the Spike protein, facilitating virus entry into cells. However, the involvement of estrogenic receptors in SARS-CoV-2 infection are still being explored. Thus, in order to investigate the role of estrogen and its receptors in COVID-19, the estrogen receptors ERα, ERβ and GPER1 were overexpressed in bronchial BEAS-2B cell, and then infected with SARS-CoV-2. Interestingly, the levels of ACE2 and TMPRSS2 mRNA were higher in SARS-CoV-2-infected cells, but no difference was observed in cells with estrogen receptors overexpression. GPER1 can be involved in virus infection or replication, since its higher levels reduces SARS-CoV-2 load. On the other hand, pharmacological antagonism of GPER1 enhanced viral load. Those data suggest that GPER1 has an important role in SARS-CoV-2 infection.

PubMed ID: 36096380
Article link: Mol Cell Endocrinol



References [+] :
Al-Kuraishy, The Looming Effects of Estrogen in Covid-19: A Rocky Rollout. 2021, Pubmed